Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

Published:2010-08 Issue:9741 Volume:376 Page:615-623
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zaman K,Anh Dang Duc,Victor John C,Shin Sunheang,Yunus Md,Dallas Michael J,Podder Goutam,Thiem Vu Dinh,Mai Le Thi Phuong,Luby Stephen P,Tho Le Huu,Coia Michele L,Lewis Kristen,Rivers Stephen B,Sack David A,Schödel Florian,Steele A Duncan,Neuzil Kathleen M,Ciarlet Max

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Global mortality associated with rotavirus disease among children in 2004;Parashar;J Infect Dis,2009

2. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries;Bresee;Vaccine,1999

3. Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine in preventing rotavirus gastroenteritis and reducing associated health care resource utilization;Vesikari;N Engl J Med,2006

4. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis;Ruis-Palacios;N Engl J Med,2006

5. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomized, double-blind, controlled study;Phua;Vaccine,2009

Cited by 599 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV;Vaccine: X;2024-08

2. IDENTIFYING PLAUSIBLE RANGES FOR DIFFERENTIAL VACCINE EFFICACY ACROSS HIGH- AND LOW-INCOME SETTINGS: A SYSTEMATIC REVIEW, DESCRIPTIVE META-ANALYSIS, AND ILLUSTRATIVE EVIDENCE ANALYSIS;2024-08-01

3. Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys;Vaccine;2024-05

4. Understanding the influence of the microbiome on childhood infections;Expert Review of Anti-infective Therapy;2024-04-12

5. Abundance of Selected Lipopolysaccharide-Rich Bacteria and Levels of Toll-like Receptor 4 and Interleukin 8 Expression Are Significantly Associated with Live Attenuated Rotavirus Vaccine Shedding among South African Infants;Vaccines;2024-03-05